Pharma Mar S.A. Strategic Asset Allocation Index
Pharma Mar S.A. strategic asset allocation index. Pharma Mar S.A. (PHM) has a Strategic Asset Allocation Index of 18.6% as of June 2023. Strategic assets (PP&E of €39.19 Million plus long-term investments of €-) total €39.19 Million, measured against net assets of €210.30 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See PHM net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Pharma Mar S.A. (2013–2022)
Strategic asset allocation index of Pharma Mar S.A. from 2013 to 2022. This chart shows how Pharma Mar S.A.'s Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of June 2023, the index stands at 18.6%, representing strategic assets of €39.19 Million against net assets of €210.30 Million EUR. Check Pharma Mar S.A. tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Pharma Mar S.A. Strategic Asset Allocation Index by Year (2013–2022)
Pharma Mar S.A. strategic asset allocation index by year from 2013 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Pharma Mar S.A. from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see PHM market cap overview.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 15.6% | €34.72 Million | €34.72 Million | €- | €222.96 Million | ▲ +0.5 pp |
| 2021 | 15.1% | €26.90 Million | €26.90 Million | €- | €177.92 Million | ▼ -9.0 pp |
| 2020 | 24.1% | €24.75 Million | €24.75 Million | €- | €102.72 Million | ▼ -333.1 pp |
| 2019 | 357.2% | €26.63 Million | €25.60 Million | €1.03 Million | €7.46 Million | ▲ +206.3 pp |
| 2018 | 150.8% | €26.36 Million | €25.47 Million | €884.00K | €17.47 Million | ▲ +13.3 pp |
| 2017 | 137.5% | €31.61 Million | €30.63 Million | €977.00K | €22.98 Million | ▲ +75.5 pp |
| 2016 | 62.0% | €30.09 Million | €28.95 Million | €1.14 Million | €48.49 Million | ▲ +19.1 pp |
| 2015 | 42.9% | €31.34 Million | €30.27 Million | €1.07 Million | €73.04 Million | ▼ -4.5 pp |
| 2014 | 47.5% | €28.50 Million | €27.43 Million | €1.07 Million | €60.07 Million | ▲ +5.8 pp |
| 2013 | 41.6% | €20.58 Million | €19.57 Million | €1.01 Million | €49.44 Million | — |